Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT1A1 | P22309 | 1/20 | 0.73 |
| ▸ | UGT1A8 | Q9HAW9 | 1/20 | 0.73 |
| ▸ | EGFR | P00533 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.53 |
| ▸ | MAPT | P10636 | 8/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | TP53 | P04637 | 6/20 | 0.53 |
| ▸ | HPGD | P15428 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 6/20 | 0.52 |
| ▸ | RAB9A | P51151 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Irisolone SCHEMBL29928854 | 1.00 | UGT1A1 (0.73) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| SCHEMBL12073700 | 0.85 | UGT1A1 (1.00) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| SCHEMBL30471499 | 0.84 | UGT1A1 (0.52) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| Irisflorentin SCHEMBL29285415 | 0.84 | ALDH1A1 (0.53) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| SCHEMBL31475104 | 0.78 | ALDH1A1 (0.52) | UGT1A1UGT1A8KDM4ESMN1; SMN2MAPT | |
| SCHEMBL29441847 | 0.78 | UGT1A1 (0.71) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| SCHEMBL29696493 | 0.78 | UGT1A1 (0.69) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| Tectorigenin SCHEMBL351641 | 0.76 | EGFR (1.00) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| Tectorigenin SCHEMBL29353966 | 0.76 | EGFR (1.00) | UGT1A1UGT1A8EGFRKDM4EPOLB | |
| SCHEMBL28274172 | 0.75 | KDM4E (0.67) | EGFRKDM4EPOLBALDH2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| CN-1986556-A | Blackberry lily isoflavone compound and its application in medical field | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2007-06-27 | — | — | CN | claimed |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | NATURAL EXTRACTION SYS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | Natural Extraction Systems, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12329303-B1 | Collapsible storage apparatus for securing packages | McNaboe, Brian J. (US) | 2025-06-17 | — | — | US | disclosed |
| CN-117897137-B | Cosmetic composition containing iris bulb-derived exosome as effective component | 瑞士派尊产品公司 | 2025-05-23 | — | — | CN | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| US-20250127709-A1 | COSMETIC COMPOSITION CONTAINING IRIS GERMANICA ROOT-DERIVED EXOSOMES AS AN ACTIVE INGREDIENT | PP Produits Prestiges SA (CH) | 2025-04-24 | — | — | US | disclosed |
| US-20020027140-A1 | MEDICAL WASTE SEGREGATION APPARATUS WITH MOVEABLE FLOOR | GEORGE SCOTT A (US) | 2002-03-07 | — | — | US | disclosed |
| WO-2001087719-A1 | MEDICAL WASTE SEGREGATION APPARATUS WITH MOVEABLE FLOOR | GEORGE SCOTT A (US) | 2001-11-22 | — | — | WO | disclosed |
| US-6209744-B1 | Hinge-doored receptacle | CALHOUN & HAASE PLLC | 2001-04-03 | — | — | US | disclosed |
| US-6000938-A | Automated door mechanism for heat treating furnace | MELANOWICZ AREK (US) | 1999-12-14 | — | — | US | disclosed |
| US-5968520-A | PLANT EXTRACTS FROM ALDER AND MOUNTAIN ASH; HANGOVER REMEDY | NAM JONG HYUN (KR) | 1999-10-19 | — | — | US | disclosed |
| EP-0878199-A1 | NATURAL TEAS FOR TAKING OFF THE EFFECTS OF DRINK AND PROCESS FOR THE PRODUCTION THEREOF | Nam, Jong Hyun (KR) | 1998-11-18 | — | — | EP | disclosed |
| US-5372271-A | Pedal actuated waste disposal bin | MILLER MICHAEL G (US) | 1994-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | UGT1A1 1445/4885UGT1A8 1189/4885EGFR 2528/4885 |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | PRKG2, PRKG1, CIT | UGT1A1 4272/4885UGT1A8 4229/4885EGFR 2451/4885 |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | SCO2, CNR2, CNR1 | UGT1A1 821/4885UGT1A8 1247/4885EGFR 2528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.